To examine whether the expression levels of TIM-1+ B-cell signature (271 genes) correlate with survival in HCC patients, we used these genes to stratify the HCC patients from The Cancer Genome Atlas (TCGA) cohort into two groups of high and low scores based on the median. The gene discussed is HAVCR1; the disease is hepatocellular carcinoma.